Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1Head & Neck 1

Conditions

Mucositis 6Head and Neck Neoplasms 3Neoplasms 2Xerostomia 1Stomatitis 1Squamous Cell Carcinoma of Head and Neck 1Radiation Injuries 1Pain 1Oral Ulcer 1Multiple Myeloma 1Leukemia 1Laryngeal Diseases 1Drug-Related Side Effects and Adverse Reactions 1Carcinoma, Squamous Cell 1

Interventions

Radiotherapy 4Radiation 3Cisplatin 3Amifostine 2pegfilgrastim 1Surgical Procedures, Operative 1Selenomethionine 1Paclitaxel 1Oral Hygiene 1Low-Level Light Therapy 1Lansoprazole 1Granulocyte Colony-Stimulating Factor 1Fluorouracil 1Filgrastim 1Fibroblast Growth Factor 7 1Docetaxel 1Dexlansoprazole 1Carboplatin 1Biotene 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Xerostomia × Fibroblast Growth Factor 7 × Other × Clear all
NCT00101582 2016-09-27

Palifermin for the Reduction of Oral Mucositis in Patients With Locally Advanced Head and Neck Cancer

Swedish Orphan Biovitrum

Phase 3 Completed
188 enrolled 19 charts
Head & NeckOther

Carcinoma, Squamous Cell, Head and Neck Neoplasms, Laryngeal Diseases, Stomatitis, Xerostomia, Oral Ulcer, Mucositis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡